Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Omnicell Inc (OMCL)

Omnicell Inc (OMCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,310,227
  • Shares Outstanding, K 46,844
  • Annual Sales, $ 1,112 M
  • Annual Income, $ 12,530 K
  • EBIT $ 11 M
  • EBITDA $ 104 M
  • 60-Month Beta 0.76
  • Price/Sales 1.17
  • Price/Cash Flow 9.08
  • Price/Book 1.04

Options Overview Details

View History
  • Implied Volatility 68.58% ( +10.49%)
  • Historical Volatility 30.17%
  • IV Percentile 84%
  • IV Rank 61.08%
  • IV High 89.58% on 04/08/25
  • IV Low 35.63% on 02/10/25
  • Put/Call Vol Ratio 0.18
  • Today's Volume 53
  • Volume Avg (30-Day) 108
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 3,117
  • Open Int (30-Day) 2,923

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 0.11
  • Number of Estimates 2
  • High Estimate 0.12
  • Low Estimate 0.10
  • Prior Year 0.32
  • Growth Rate Est. (year over year) -65.63%

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.84 +0.13%
on 07/18/25
30.57 -12.07%
on 07/01/25
-1.39 (-4.92%)
since 06/18/25
3-Month
22.66 +18.62%
on 05/06/25
32.18 -16.47%
on 05/02/25
-3.40 (-11.23%)
since 04/17/25
52-Week
22.66 +18.62%
on 05/06/25
55.74 -51.78%
on 10/30/24
-0.64 (-2.33%)
since 07/18/24

Most Recent Stories

More News
Can OPRX's Patient Engagement Tools Win Amid Fierce Competition?

OptimizeRx OPRX delivered an encouraging first-quarter 2025, with revenues rising 11% year over year to $21.9 million and adjusted EBITDA reaching $1.5 million — a significant year-over-year turnaround....

OMCL : 26.88 (-3.90%)
OPRX : 12.97 (-7.29%)
TDOC : 8.05 (+0.12%)
Do Options Traders Know Something About Omnicell Stock We Don't?

Investors in Omnicell, Inc. OMCL need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 17, 2025 $25 Call had some of the highest implied volatility...

OMCL : 26.88 (-3.90%)
Do Options Traders Know Something About Omnicell Stock We Don't?

Investors in Omnicell, Inc. OMCL need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 17, 2025 $25 Call had some of the highest implied volatility...

OMCL : 26.88 (-3.90%)
Is it Apt to Retain Omnicell Stock in Your Portfolio Now?

Omnicell OMCL is advancing toward the industry-defined vision of Autonomous Pharmacy by leveraging automation and advanced services across its cloud-based platform. OMCL’s progress toward its 2025 financial...

INSP : 126.83 (-0.89%)
OMCL : 26.88 (-3.90%)
PBH : 75.77 (+0.85%)
PAHC : 29.41 (-1.08%)
Omnicell: Q1 Earnings Snapshot

Omnicell: Q1 Earnings Snapshot

OMCL : 26.88 (-3.90%)
Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers Stocks

Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers Stocks

OMCL : 26.88 (-3.90%)
EVH : 9.53 (-15.44%)
ASTH : 22.65 (-8.26%)
PHR : 25.48 (-1.74%)
PINC : 20.95 (-0.57%)
Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers Stocks

Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers Stocks

OMCL : 26.88 (-3.90%)
EVH : 9.53 (-15.44%)
ASTH : 22.65 (-8.26%)
PHR : 25.48 (-1.74%)
PINC : 20.95 (-0.57%)
Unpacking Q4 Earnings: Omnicell (NASDAQ:OMCL) In The Context Of Other Healthcare Technology for Providers Stocks

Unpacking Q4 Earnings: Omnicell (NASDAQ:OMCL) In The Context Of Other Healthcare Technology for Providers Stocks

OMCL : 26.88 (-3.90%)
EVH : 9.53 (-15.44%)
ASTH : 22.65 (-8.26%)
PHR : 25.48 (-1.74%)
PINC : 20.95 (-0.57%)
1 of Wall Street’s Favorite Stock to Target This Week and 2 to Keep Off Your Radar

1 of Wall Street’s Favorite Stock to Target This Week and 2 to Keep Off Your Radar

OMCL : 26.88 (-3.90%)
ANIP : 66.30 (-2.56%)
TGLS : 74.91 (-0.53%)
Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks

Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks

OMCL : 26.88 (-3.90%)
TNDM : 14.77 (-3.84%)
EVH : 9.53 (-15.44%)
PHR : 25.48 (-1.74%)
PINC : 20.95 (-0.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution,...

See More

Key Turning Points

3rd Resistance Point 29.83
2nd Resistance Point 29.22
1st Resistance Point 28.05
Last Price 26.88
1st Support Level 26.28
2nd Support Level 25.67
3rd Support Level 24.50

See More

52-Week High 55.74
Fibonacci 61.8% 43.11
Fibonacci 50% 39.20
Fibonacci 38.2% 35.30
Last Price 26.88
52-Week Low 22.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar